Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
The study was stopped due to Pfizer (sponsor) decision that the compound would not be involved in any further clinical development for the indication of resistant hypertension on 05 August 2008. This decision was not based on any safety or efficacy concern.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of resistant hypertension.
A stable anti-hypertensive drug regimen for at least 30 days.
You may not be if
Sustained blood pressure greater than or equal to 180/120 mmHg.
Required use of thigh cuff for blood pressure readings.